| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A phase I study to determine the safety, tolerability and maximum tolerated dose of green-lipped mussel (Perna canaliculus) lipid extract, in patients with advanced prostate and breast cancer
|
Sukumaran, S.
|
|
|
21 |
5 |
p. 1089-1093
|
article
|
| 2 |
A window of opportunity phase II study of enzastaurin in chemonaive patients with asymptomatic metastatic colorectal cancer
|
Glimelius, B.
|
|
|
21 |
5 |
p. 1020-1026
|
article
|
| 3 |
Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT)
|
Niwińska, A.
|
|
|
21 |
5 |
p. 942-948
|
article
|
| 4 |
Characteristics of cancer patients using homeopathy compared with those in conventional care: a cross-sectional study
|
Guethlin, C.
|
|
|
21 |
5 |
p. 1094-1099
|
article
|
| 5 |
Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents
|
Tol, J.
|
|
|
21 |
5 |
p. 1006-1012
|
article
|
| 6 |
Components of the metabolic syndrome in 500 adult long-term survivors of childhood cancer
|
van Waas, M.
|
|
|
21 |
5 |
p. 1121-1126
|
article
|
| 7 |
Cost-effectiveness of CT and PET-CT for determining the need for adjuvant neck dissection in locally advanced head and neck cancer
|
Sher, D.J.
|
|
|
21 |
5 |
p. 1072-1077
|
article
|
| 8 |
Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial
|
Joensuu, H.
|
|
|
21 |
5 |
p. 968-973
|
article
|
| 9 |
Does HER2 status influence locoregional failure rates in breast cancer patients treated with mastectomy for pT1–2pN0 disease?
|
Kwan, W.
|
|
|
21 |
5 |
p. 988-993
|
article
|
| 10 |
Double-blind, randomised, controlled study of the efficacy and tolerability of palonosetron plus dexamethasone for 1 day with or without dexamethasone on days 2 and 3 in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy
|
Aapro, M.
|
|
|
21 |
5 |
p. 1083-1088
|
article
|
| 11 |
Editorial Board
|
|
|
|
21 |
5 |
p. ii-iii
|
article
|
| 12 |
End of life in cancer patients: drugs or words?
|
Aitini, E.
|
|
|
21 |
5 |
p. 914-915
|
article
|
| 13 |
Experience with fulvestrant acetate in castration-resistant prostate cancer patients
|
Blesa, J.M. Gasent
|
|
|
21 |
5 |
p. 1131-1132
|
article
|
| 14 |
HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancer
|
Schoppmann, S.F.
|
|
|
21 |
5 |
p. 955-960
|
article
|
| 15 |
High dose intensity doxorubicin in aggressive non-Hodgkin's lymphoma: a literature-based meta-analysis
|
Azim, H.A.
|
|
|
21 |
5 |
p. 1064-1071
|
article
|
| 16 |
Hodgkin’s lymphoma in remission after first-line therapy: which patients need FDG–PET/CT for follow-up?
|
Petrausch, U.
|
|
|
21 |
5 |
p. 1053-1057
|
article
|
| 17 |
Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy
|
Villa, D.
|
|
|
21 |
5 |
p. 1046-1052
|
article
|
| 18 |
Incidence of brain metastases in renal cell carcinoma treated with sorafenib
|
Massard, C.
|
|
|
21 |
5 |
p. 1027-1031
|
article
|
| 19 |
Increasing incidence rates of soft tissue sarcomas? A population-based epidemiologic study and literature review
|
Wibmer, C.
|
|
|
21 |
5 |
p. 1106-1111
|
article
|
| 20 |
In this issue
|
|
|
|
21 |
5 |
p. 909
|
article
|
| 21 |
Lack of prophylaxis before the onset of acute venous thromboembolism among hospitalized cancer patients: the SWIss Venous ThromboEmbolism Registry (SWIVTER)
|
Kucher, N.
|
|
|
21 |
5 |
p. 931-935
|
article
|
| 22 |
Long-term follow-up of chemonaive patients with asymptomatic metastatic colorectal cancer treated with enzastaurin in a window of opportunity phase II study
|
Glimelius, B.
|
|
|
21 |
5 |
p. 1127-1128
|
article
|
| 23 |
Long-term survivors among breast cancer patients with brain metastases
|
Arik, Z.
|
|
|
21 |
5 |
p. 1128
|
article
|
| 24 |
Low-dose tamoxifen in the treatment of breast ductal intraepithelial neoplasia: results of a large observational study
|
Guerrieri-Gonzaga, A.
|
|
|
21 |
5 |
p. 949-954
|
article
|
| 25 |
Management of neuropathic cancer pain
|
Attal, N.
|
|
|
21 |
5 |
p. 1134-1135
|
article
|
| 26 |
Management of occult invasive cervical cancer found after simple hysterectomy
|
Park, J.-Y.
|
|
|
21 |
5 |
p. 994-1000
|
article
|
| 27 |
Menopausal symptoms in women undergoing chemotherapy-induced and natural menopause: a prospective controlled study
|
Mar Fan, H.G.
|
|
|
21 |
5 |
p. 983-987
|
article
|
| 28 |
Molecular prognosticators of complex karyotype soft tissue sarcoma outcome: a tissue microarray-based study
|
Lahat, G.
|
|
|
21 |
5 |
p. 1112-1120
|
article
|
| 29 |
Optimizing the size variation threshold for the CT evaluation of response in metastatic renal cell carcinoma treated with sunitinib
|
Thiam, R.
|
|
|
21 |
5 |
p. 936-941
|
article
|
| 30 |
Patterns of care in Dutch postmenopausal patients with hormone-sensitive early breast cancer participating in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial
|
van Nes, J.G.H.
|
|
|
21 |
5 |
p. 974-982
|
article
|
| 31 |
Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study)
|
Koizumi, W.
|
|
|
21 |
5 |
p. 1001-1005
|
article
|
| 32 |
Possible alternative strategy for stage I imatinib-sensitive testicular seminoma; lessons from a case associated with Philadelphia chromosome-positive acute lymphoblastic leukemia
|
Okamura, A.
|
|
|
21 |
5 |
p. 1129-1130
|
article
|
| 33 |
Prevalence of mental health conditions in cancer patients in acute care—a meta-analysis
|
Singer, S.
|
|
|
21 |
5 |
p. 925-930
|
article
|
| 34 |
Primary cardiac lymphoma: B- and T-cell cases at a specialist UK centre
|
Patel, J.
|
|
|
21 |
5 |
p. 1041-1045
|
article
|
| 35 |
Primary thymic seminoma in a 32-year-old female
|
Chen, Z.-G.
|
|
|
21 |
5 |
p. 1132-1134
|
article
|
| 36 |
Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type
|
Suzuki, R.
|
|
|
21 |
5 |
p. 1032-1040
|
article
|
| 37 |
Prognostic value of 18F-FDG PET/CT before and after radiotherapy for locally advanced nasopharyngeal carcinoma
|
Xie, P.
|
|
|
21 |
5 |
p. 1078-1082
|
article
|
| 38 |
Reversibility of capillary density after discontinuation of bevacizumab treatment
|
Steeghs, N.
|
|
|
21 |
5 |
p. 1100-1105
|
article
|
| 39 |
Table of Contents
|
|
|
|
21 |
5 |
p. iv-vi
|
article
|
| 40 |
The impact of carcinoembryonic antigen flare in patients with advanced colorectal cancer receiving first-line chemotherapy
|
Strimpakos, A.S.
|
|
|
21 |
5 |
p. 1013-1019
|
article
|
| 41 |
Trastuzumab treatment in patients with breast cancer and metastatic CNS disease
|
Pieńkowski, T.
|
|
|
21 |
5 |
p. 917-924
|
article
|
| 42 |
Treatment with the mTOR inhibitor temsirolimus in patients with malignant PEComa
|
Italiano, A.
|
|
|
21 |
5 |
p. 1135-1137
|
article
|
| 43 |
Tumor response to sunitinib malate observed in clear-cell sarcoma
|
Stacchiotti, S.
|
|
|
21 |
5 |
p. 1130-1131
|
article
|
| 44 |
Video meliora proboque sed deteriora sequor: the case of thromboprophylaxis in hospitalized cancer patients
|
Mandala, M.
|
|
|
21 |
5 |
p. 911-913
|
article
|
| 45 |
Weekly paclitaxel plus carboplatin is an effective nonanthracycline-containing regimen as neoadjuvant chemotherapy for breast cancer
|
Chen, X.S.
|
|
|
21 |
5 |
p. 961-967
|
article
|
| 46 |
When do we need central nervous system prophylaxis in patients with extranodal NK/T-cell lymphoma, nasal type?
|
Kim, S.J.
|
|
|
21 |
5 |
p. 1058-1063
|
article
|
Journal description